Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
08.04. | SANUWAVE Health sees Q1 revenue between $9.1m and $9.3M | 2 | Seeking Alpha | ||
08.04. | SANUWAVE reports record Q1 revenue, eyes robust 2025 | 2 | Investing.com | ||
SANUWAVE HEALTH Aktie jetzt für 0€ handeln | |||||
08.04. | SANUWAVE Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
08.04. | SANUWAVE Health, Inc.: SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2025 (Ended March 31, 2025) | 2 | GlobeNewswire (USA) | ||
22.03. | Sanuwave Health: Umsatzwachstum trotz Verlusten im letzten Quartal | 4 | IT BOLTWISE | ||
21.03. | SANUWAVE Health reports Q4 results | 2 | Seeking Alpha | ||
21.03. | SANUWAVE Health, Inc. - 8-K, Current Report | - | SEC Filings | ||
20.03. | SANUWAVE Health, Inc. - 10-K, Annual Report | 4 | SEC Filings | ||
07.03. | SANUWAVE Health, Inc. - 8-K, Current Report | - | SEC Filings | ||
06.03. | SANUWAVE Health, Inc. - 8-A12B, Registration of securities | - | SEC Filings | ||
04.03. | SANUWAVE Health, Inc.: Sanuwave Health to Uplist to the Nasdaq Global Market | 131 | GlobeNewswire (Europe) | EDEN PRAIRIE, Minn., March 04, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave") (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, announced... ► Artikel lesen | |
10.01. | SANUWAVE Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
03.12.24 | SANUWAVE Health, Inc. - S-1, General form for registration of securities | - | SEC Filings | ||
08.11.24 | SANUWAVE Health reports Q3 results | 1 | Seeking Alpha | ||
08.11.24 | SANUWAVE Health, Inc.: SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results | 137 | GlobeNewswire (Europe) | Q3 2024 revenues were $9.4 million, up 89% from Q3 2023. This was an all-time quarterly record for the Company. Q3 2024 gross margin was 75.5%, vs 71.5% in Q3 2023 GAAP Operating Income was $2.0 million... ► Artikel lesen | |
08.11.24 | SANUWAVE Health, Inc. - 8-K, Current Report | - | SEC Filings | ||
07.11.24 | SANUWAVE Health, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
18.10.24 | SANUWAVE Health, Inc.: SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering | 126 | GlobeNewswire (Europe) | 1-for-375 reverse stock split effective at market open today Exchanged $43.2 million in principal amount of convertible notes and warrants previously exercisable for approximately 1.7 billion pre-split... ► Artikel lesen | |
16.10.24 | SANUWAVE Health, Inc.: SANUWAVE Health Announces 1-For-375 Reverse Stock Split | 148 | GlobeNewswire (Europe) | Common Stock Will Begin Trading on a Split-adjusted Basis on October 18, 2024 EDEN PRAIRIE, Minn., Oct. 16, 2024 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the "Company" or "SANUWAVE") (OTCQB: SNWV)... ► Artikel lesen | |
13.08.24 | SANUWAVE Health, Inc.: SANUWAVE Announces Record Quarterly Revenues: Q2 FY2024 Financial Results | 117 | GlobeNewswire (Europe) | Q2 2024 revenues were $7.2 million, up 53% from Q2 2023. This was an all-time quarterly record for the Company. Q2 2024 Gross Margin was 73%, vs 74% in Q2 2023 GAAP Operating Income was $2.0... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PROCEPT BIOROBOTICS | 52,56 | 0,00 % | PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops | ||
BRIGHTSPRING HEALTH SERVICES | 16,550 | 0,00 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., March 06, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
ALIGNMENT HEALTHCARE | 18,040 | 0,00 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2024 Results; Provides Full-Year 2025 Financial Guidance | Reports 189,100 health plan members as of Dec. 31, 2024, up 58.6% year-over-year, beating year-end expectationsAchieves first full year of positive adjusted EBITDA as a public company, driven by operating... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 46,780 | +1,96 % | EQS-DD: Siemens Healthineers AG: Darleen Caron, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
22.04.2025 / 17:45... ► Artikel lesen | |
FRESENIUS | 40,240 | +0,98 % | BARCLAYS stuft Fresenius SE auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Fresenius von 44,00 auf 43,50 Euro gesenkt, aber die Einstufung auf "Overweight" belassen. Die Bad Homburger dürften... ► Artikel lesen | |
LIFESTANCE HEALTH GROUP | 6,490 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2024 Results | SCOTTSDALE, Ariz., Feb. 27, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 43,110 | +1,55 % | BARCLAYS stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für FMC von 42,50 auf 40,50 Euro gesenkt, aber die Einstufung auf "Equal Weight" belassen. Die schwere Grippewelle... ► Artikel lesen | |
GERRESHEIMER | 54,40 | +1,49 % | UBS stuft GERRESHEIMER AG auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat das Kursziel für Gerresheimer von 106 auf 97 Euro gesenkt, aber die Einstufung auf "Buy" belassen. Der Jahresstart sei schwach gewesen, schrieb... ► Artikel lesen | |
UNITEDHEALTH | 374,75 | +0,51 % | UnitedHealth Group-Aktie leicht im Minus (377,1447 €) | Am US-amerikanischen Aktienmarkt liegt die UnitedHealth Group-Aktie zur Stunde im Minus. Zuletzt zahlten Investoren für das Wertpapier 434,12 US-Dollar. Heute hat sich im US-amerikanischen Wertpapierhandel... ► Artikel lesen | |
CARL ZEISS MEDITEC | 58,85 | +0,17 % | Hat Carl Zeiss Meditec die Digitalisierung der Augenheilkunde in der Hand? | Der Jenaer Medizintechnikkonzern Carl Zeiss Meditec AG (DE0005313704) feiert einen beachtlichen Meilenstein im US-Markt: Mehr als zwei Millionen Kataraktoperationen wurden inzwischen mit dem digitalen... ► Artikel lesen | |
NUTEX HEALTH | 140,51 | 0,00 % | Nutex Health Inc. (NUTX): Among Most Expensive Stocks Insiders Are Buying After Trump's Tariff Rollout | ||
GENEDX | 109,22 | 0,00 % | GeneDx To Buy Fabric Genomics | ||
RXSIGHT | 14,730 | 0,00 % | RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance | ALISO VIEJO, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen | |
ECKERT & ZIEGLER | 57,70 | +2,85 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler unterzeichnet Herstellungsvereinbarung mit Pentixapharm für Yttrium-90-basiertes PentixaTher | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Vereinbarung/Auftragseingänge
Eckert & Ziegler unterzeichnet Herstellungsvereinbarung mit Pentixapharm für Yttrium-90-basiertes... ► Artikel lesen | |
DOCGO | 2,220 | 0,00 % | Pre-market Movers: Interactive Strength, DocGo, DLocal, Iovance Biotherapeutics, Acadia Healthcare | BRASILIA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 09.00 A.M. ET).In the Green Interactive Strength Inc. (TRNR) is up over 30% at... ► Artikel lesen |